Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ENDRA Life Sciences Inc.NDRA · Entity 8083 | Director | April 09, 2020 | April 13, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ENDRA Life Sciences Inc.
Report date April 09, 2020 · Filed April 13, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,857 |
Reported balance
After 2020-04-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-04-09 · Grant · Acquired 42,857 · Balance 42,857 F1: Represents restricted stock units granted in lieu of the Reporting Person's cash retainer payable under the Issuer's Non-Employee Director Compensation Policy for the second, third and fourth quarters of 2020. The restricted stock units vest in three equal installments on the last day of each such calendar quarter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2: Includes unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted in lieu of the Reporting Person's cash retainer payable under the Issuer's Non-Employee Director Compensation Policy for the second, third and fourth quarters of 2020. The restricted stock units vest in three equal installments on the last day of each such calendar quarter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2: Includes unvested restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 09, 2020 Filed Apr 13, 2020 16:50 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantCommon Stock | 42,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-024218 · doc4.xml · nonDerivative · entry 1 Gambhir Sanjiv Sam · CIK 0001369005 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,857 F1 · shares: Represents restricted stock units granted in lieu of the Reporting Person's cash retainer payable under the Issuer's Non-Employee Director Compensation Policy for the second, third and fourth quarters of 2020. The restricted stock units vest in three equal installments on the last day of each such calendar quarter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:21 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantStock Options · Derivative | 12,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001209191-20-001787 · doc4.xml · derivative · entry 1 Gambhir Sanjiv Sam · CIK 0001369005 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2030-01-02 F1 · shares: Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| December 11, 2019 Filed Dec 11, 2019 17:48 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantStock option (right to buy) · Derivative | 89,585 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001209191-19-060086 · doc4.xml · derivative · entry 1 Gambhir Sanjiv Sam · CIK 0001369005 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,585 Underlying: Common Stock · 89,585 shares Expires 2029-12-11 F1 · derivative.exercise_date: These options vest and become exercisable in three equal annual installments beginning on the one year anniversary of the grant date. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 20:00 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantStock Options · Derivative | 50,000 | $0.00 Strike: $3.09 | $0.00 |
DisclosureSEC source: 0001209191-19-021504 · doc4.xml · derivative · entry 1 Gambhir Sanjiv Sam · CIK 0001369005 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2019-03-25 F1 · shares: Represents a stock option award granted on March 25, 2019 pursuant to the Issuer's Non-Employee Director Compensation Policy. F2 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning March 25, 2020. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:24 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantStock Options · Derivative | 6,061 | $0.00 Strike: $4.95 | $0.00 |
DisclosureSEC source: 0001654954-18-000112 · section16.xml · derivative · entry 1 Gambhir Sanjiv Sam · CIK 0001369005 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,061 Underlying: Common Stock · 6,061 shares Expires 2026-01-02 F1 · shares: Represents a stock option award granted on January 2, 2018 pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| May 12, 2017 Filed May 23, 2017 17:58 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantStock Options · Derivative | 6,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001209191-17-034724 · doc4.xml · derivative · entry 2 Gambhir Sanjiv Sam · CIK 0001369005 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2025-05-12 Read SEC document |
| May 12, 2017 Filed May 23, 2017 17:58 UTC | ENDRA Life Sciences Inc. NDRA · Entity 8083 | GrantStock Options · Derivative | 6,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001209191-17-034724 · doc4.xml · derivative · entry 1 Gambhir Sanjiv Sam · CIK 0001369005 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2025-05-12 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.